Institut de la Vision, Inserm, UPMC, CNRS, CHNO des XV-XX
(0)1 53 46 25 04
©Schéma : InsermResearchers at Tübingen University in Germany have succeeded in partially restoring the eyesight to six patients (out of nine treated) who were suffering from retinitis pigmentosa thanks to a prosthesis known as Retina. This genetic condition involves a progressive reduction in sight until the patient becomes totally blind, due to a loss of photoreceptors in the eye. The Retina is not the only promising procedure for use as a retinal prosthesis. The U.S. Federal Drug Administration (FDA) last week approved the introduction into the market of the first bionic eye, known as ”Argus 2”, which has already been approved by the European authorities. This bionic eye, grafted on to sixty blind people throughout the world, makes it possible to stimulate the optic nerve using video systems and a wireless electric charge. To learn more about it, please contact José-Alain Sahel director of the Vision Institute and head of the Ophthalmology Department at the Quinze-Vingts Hospital in Paris.